Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor

Inhibition of the myostatin signaling pathway is emerging as a promising therapeutic means to treat muscle wasting and degenerative disorders. Activin type IIB receptor (ActRIIB) is the putative myostatin receptor, and a soluble activin receptor (ActRIIB-Fc) has been demonstrated to potently inhibit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rahimov, Fedik, King, Oliver D., Warsing, Leigh C., Powell, Rachel E., Emerson, Charles P., Kunkel, Louis M., Wagner, Kathryn R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Physiological Society 2011
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3092338/
https://ncbi.nlm.nih.gov/pubmed/21266502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/physiolgenomics.00223.2010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak